Clinical Trials Browser

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Phase 2 Completed

53 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

Clinical Trials

T-DIS

TRABEPIO

Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

Trabectedin for Recurrent Grade II/III Meningioma

STRADA

NCT-PMO-1603

NiTraSarc

TRAVELL

MITO 26

ATREUS

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

TR1US

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

TAUL

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

PACT-18

Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma

A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram

A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer

An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma

Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma

ET 743 (Yondelis) in Men With Advanced Prostate Cancer

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer